IDO1 and Merkel cell skin cancer: Wardhani et al. [9] reported that higher tumoral IDO1 expression was significantly correlated with worse OS in 43 MCC patients, and enhanced tumoral IDO1 immunoreactivity was correlated with MCPyV-positive status.